These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7232638)

  • 1. The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics [proceedings].
    Goldberg SC; Shenoy RS; Sadler A; Hamer R; Ross B
    Psychopharmacol Bull; 1981 Jan; 17(1):116-7. PubMed ID: 7232638
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluphenazine and tardive dyskinesia.
    Perényi A; Arató M
    Arch Gen Psychiatry; 1984 Jul; 41(7):727. PubMed ID: 6732436
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.
    Kane JM; Rifkin A; Woerner M; Reardon G; Sarantakos S; Schiebel D; Ramos-Lorenzi J
    Arch Gen Psychiatry; 1983 Aug; 40(8):893-6. PubMed ID: 6347119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
    Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year.
    Rifkin A; Quitkin F; Rabiner CJ; Klein DF
    Arch Gen Psychiatry; 1977 Jan; 34(1):43-7. PubMed ID: 189724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a six-week drug holiday on symptom status, relapse, and tardive dyskinesia in chronic schizophrenics.
    Shenoy RS; Sadler AG; Goldberg SC; Hamer RM; Ross B
    J Clin Psychopharmacol; 1981 May; 1(3):141-5. PubMed ID: 6117584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the use of fluphenazine in a depot preparation].
    Marcjan K; Pietruszewska I; Wolak E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():176-82. PubMed ID: 829619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive oculogyric crisis and obsessional thoughts.
    Sachdev P
    Br J Psychiatry; 1991 May; 158():720-1. PubMed ID: 1860035
    [No Abstract]   [Full Text] [Related]  

  • 12. Depot fluphenazine and tardive dyskinesia.
    Gibson AC
    Br Med J; 1978 Aug; 2(6134):434. PubMed ID: 687963
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluphenazine decanoate and tardive dyskinesia: a possible association.
    Csernansky JG; Grabowski K; Cervantes J; Kaplan J; Yesavage JA
    Am J Psychiatry; 1981 Oct; 138(10):1362-5. PubMed ID: 7294195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and depot fluphenazine.
    Wiles D
    Br J Psychiatry; 1979 Oct; 135():382-3. PubMed ID: 519126
    [No Abstract]   [Full Text] [Related]  

  • 15. Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate.
    Steiner S; Nagy C
    Int Pharmacopsychiatry; 1981; 16(3):184-92. PubMed ID: 7319750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluphenazine decanoate and tardive dyskinesia.
    Schiff AA
    Am J Psychiatry; 1982 Jul; 139(7):969-70. PubMed ID: 6124136
    [No Abstract]   [Full Text] [Related]  

  • 17. Promoting compliance with outpatient drug treatment.
    Frances A; Weiden P
    Hosp Community Psychiatry; 1987 Nov; 38(11):1158-60. PubMed ID: 3666712
    [No Abstract]   [Full Text] [Related]  

  • 18. Depot injections and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Oct; 133():361-5. PubMed ID: 709010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of fluphenazines in a continuing-care program.
    Owens D
    Hosp Community Psychiatry; 1978 Feb; 29(2):115-8. PubMed ID: 620998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.